Melissa K Thomas

7PUBLICATIONS
16CO-AUTHORS
Predictive and prognostic markersGene and molecular therapyEpigenetics (incl. genome methylation and epigenomics)PharmacogenomicsAboriginal and Torres Strait Islander theory of change models for health
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Aug 17, 2026
Retatrutide-Associated Improvements in Cardiovascular Risk Biomarkers in Adults With Obesity With or Without Type 2 Diabetes.

|Aug 20, 2025
Mazdutide reduces body weight in adults with overweight or obesity: A high-dose Phase 1 trial.

Shobha N Bhattachar, Lai San Tham, Yan Li

|Jul 29, 2025
Decreases in circulating ANGPTL3/8 concentrations following retatrutide treatment parallel reductions in serum lipids.

Yi Wen, Deven Lemen, Yanzhu Lin

|May 25, 2024
Effects of Tirzepatide vs Semaglutide on β-Cell Function, Insulin Sensitivity, and Glucose Control During a Meal Test.

Kieren J Mather, Andrea Mari, Tim Heise

|Jan 22, 2024
Tirzepatide Improved Markers of Islet Cell Function and Insulin Sensitivity in People With T2D (SURPASS-2).

Juan P Frias, Christophe De Block, Katelyn Brown

|Mar 01, 2023
Tirzepatide Reduces Appetite, Energy Intake, and Fat Mass in People With Type 2 Diabetes.

Tim Heise, J Hans DeVries, Shweta Urva

Pageof 2

Frequent Collaborators

4 joint publications

Axel Haupt

4 joint publications

Tamer Coskun

3 joint publications

Kieren J Mather

3 joint publications

Giacomo Ruotolo